MTOR complex 1: A key player in neuroadaptations induced by drugs of abuse

Journal of Neurochemistry

Volumn 130, Issue 2, 2014, Pages 172-184

  Neasta, Jeremie ^a,b   Barak, Segev ^a,b,c   Hamida, Sami Ben ^a,b,d   Ron, Dorit ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

^d INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

addiction; alcohol; drugs of abuse; limbic system; mTOR; translation

Indexed keywords

ALCOHOL; CANNABINOID; CENTRAL STIMULANT AGENT; COCAINE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MESSENGER RNA; METHAMPHETAMINE; MORPHINE; OPIATE; PROTEIN SERINE THREONINE KINASE; RAPAMYCIN;

ADAPTATION; ADDICTION; BRAIN FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; HUMAN; LEARNING; MEMORY; NEUROADAPTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; RNA TRANSLATION; SIGNAL TRANSDUCTION;

MAMMALIA;

ADDICTION; ALCOHOL; DRUGS OF ABUSE; LIMBIC SYSTEM; MTOR; TRANSLATION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; AUTOPHAGY; BEHAVIOR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPROTEIN COMPLEXES; NEURONS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SIROLIMUS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; SYNAPTIC TRANSMISSION; TOR SERINE-THREONINE KINASES;

EID: 84904046781     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12725     Document Type: Review

References (117)

1. Autry A. E., and, Monteggia L. M., (2012) Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol. Rev. 64, 238-258.
2. Autry A. E., Adachi M., Nosyreva E., Na E. S., Los M. F., Cheng P. F., Kavalali E. T., and, Monteggia L. M., (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475, 91-95.
3. Bailey J., Ma D., and, Szumlinski K. K., (2012) Rapamycin attenuates the expression of cocaine-induced place preference and behavioral sensitization. Addict. Biol. 17, 248-258.
4. Barak S., Liu F., Ben Hamida S., Yowell Q. V., Neasta J., Kharazia V., Janak P. H., and, Ron D., (2013) Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse. Nat. Neurosci. 16, 1111-1117.
5. Bekinschtein P., Katche C., Slipczuk L. N., Igaz L. M., Cammarota M., Izquierdo I., and, Medina J. H., (2007) mTOR signaling in the hippocampus is necessary for memory formation. Neurobiol. Learn. Mem. 87, 303-307. (Pubitemid 46038946)
6. Belelovsky K., Kaphzan H., Elkobi A., and, Rosenblum K., (2009) Biphasic activation of the mTOR pathway in the gustatory cortex is correlated with and necessary for taste learning. J. Neurosci. 29, 7424-7431.
7. Ben Hamida S., Neasta J., Lasek A. W., Kharazia V., Zou M., Carnicella S., Janak P. H., and, Ron D., (2012) The small G protein H-Ras in the mesolimbic system is a molecular gateway to alcohol-seeking and excessive drinking behaviors. J. Neurosci. 32, 15849-15858.
8. Blundell J., Kouser M., and, Powell C. M., (2008) Systemic inhibition of mammalian target of rapamycin inhibits fear memory reconsolidation. Neurobiol. Learn. Mem. 90, 28-35.
9. Cammalleri M., Lutjens R., Berton F., King A. R., Simpson C., Francesconi W., and, Sanna P. P., (2003) Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1. Proc. Natl Acad. Sci. USA 100, 14368-14373. (Pubitemid 37499243)
10. Costa-Mattioli M., and, Monteggia L. M., (2013) mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat. Neurosci. 16, 1537-1543.
11. Costa-Mattioli M., Sossin W. S., Klann E., and, Sonenberg N., (2009) Translational control of long-lasting synaptic plasticity and memory. Neuron 61, 10-26.
12. Cozzoli D. K., Goulding S. P., Zhang P. W., et al,. (2009) Binge drinking upregulates accumbens mGluR5-Homer2-PI3K signaling: functional implications for alcoholism. J. Neurosci. 29, 8655-8668.
13. Cui Y., Zhang X. Q., Xin W. J., Jing J., and, Liu X. G., (2010) Activation of phosphatidylinositol 3-kinase/Akt-mammalian target of Rapamycin signaling pathway in the hippocampus is essential for the acquisition of morphine-induced place preference in rats. Neuroscience 171, 134-143.
14. Davies S. P., Reddy H., Caivano M., and, Cohen P., (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105.
15. Dayas C. V., Smith D. W., and, Dunkley P. R., (2012) An emerging role for the Mammalian target of rapamycin in "pathological" protein translation: relevance to cocaine addiction. Front. Pharmacol. 3, 13.
16. Dazert E., and, Hall M. N., (2011) mTOR signaling in disease. Curr. Opin. Cell Biol. 23, 744-755.
17. Dehay B., Bove J., Rodriguez-Muela N., Perier C., Recasens A., Boya P., and, Vila M., (2010) Pathogenic lysosomal depletion in Parkinson's disease. J. Neurosci. 30, 12535-12544.
18. Deli A., Schipany K., Rosner M., Hoger H., Pollak A., Li L., Hengstschlager M., and, Lubec G., (2012) Blocking mTORC1 activity by rapamycin leads to impairment of spatial memory retrieval but not acquisition in C57BL/6J mice. Behav. Brain Res. 229, 320-324.
19. Demirkan G., Yu K., Boylan J. M., Salomon A. R., and, Gruppuso P. A., (2011) Phosphoproteomic profiling of in vivo signaling in liver by the mammalian target of rapamycin complex 1 (mTORC1). PLoS ONE 6, e21729.
20. Derkinderen P., Valjent E., Toutant M., Corvol J. C., Enslen H., Ledent C., Trzaskos J., Caboche J., and, Girault J. A., (2003) Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J. Neurosci. 23, 2371-2382. (Pubitemid 36368926)
21. Domanskyi A., Geissler C., Vinnikov I. A., Alter H., Schober A., Vogt M. A., Gass P., Parlato R., and, Schutz G., (2011) Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models. FASEB J. 25, 2898-2910.
22. Dowling R. J., Topisirovic I., Fonseca B. D., and, Sonenberg N., (2010) Dissecting the role of mTOR: Lessons from mTOR inhibitors. Biochim. Biophys. Acta 1804, 433-439.
23. Gafford G. M., Parsons R. G., and, Helmstetter F. J., (2011) Consolidation and reconsolidation of contextual fear memory requires mammalian target of rapamycin-dependent translation in the dorsal hippocampus. Neuroscience 182, 98-104.
24. Girault J. A., Valjent E., Caboche J., and, Herve D., (2007) ERK2: a logical AND gate critical for drug-induced plasticity? Curr. Opin. Pharmacol. 7, 77-85. (Pubitemid 46238037)
25. Glover E. M., Ressler K. J., and, Davis M., (2010) Differing effects of systemically administered rapamycin on consolidation and reconsolidation of context vs. cued fear memories. Learn. Mem. 17, 577-581.
26. Gobert D., Topolnik L., Azzi M., Huang L., Badeaux F., Desgroseillers L., Sossin W. S., and, Lacaille J. C., (2008) Forskolin induction of late-LTP and up-regulation of 5' TOP mRNAs translation via mTOR, ERK, and PI3K in hippocampal pyramidal cells. J. Neurochem. 106, 1160-1174.
27. Goncalves J., Baptista S., Olesen M. V., Fontes-Ribeiro C., Malva J. O., Woldbye D. P., and, Silva A. P., (2012) Methamphetamine-induced changes in the mice hippocampal neuropeptide Y system: implications for memory impairment. J. Neurochem. 123, 1041-1053.
28. Gong R., Park C. S., Abbassi N. R., and, Tang S. J., (2006) Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons. J. Biol. Chem. 281, 18802-18815. (Pubitemid 44043076)
29. Halloran J., Hussong S., Burbank R., et al,. (2012) Chronic inhibition of mTOR by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice. Neuroscience 223, 102-113.
30. Harris H., and, Rubinsztein D. C., (2012) Control of autophagy as a therapy for neurodegenerative disease. Nat. Rev. Neurol. 8, 108-117.
31. Hartford C. M., and, Ratain M. J., (2007) Rapamycin: something old, something new, sometimes borrowed and now renewed. Clin. Pharmacol. Ther. 82, 381-388. (Pubitemid 47414349)
32. Hay N., and, Sonenberg N., (2004) Upstream and downstream of mTOR. Genes Dev. 18, 1926-1945. (Pubitemid 39071573)
33. Hernandez D., Torres C. A., Setlik W., et al,. (2012) Regulation of presynaptic neurotransmission by macroautophagy. Neuron 74, 277-284.
34. Hoeffer C. A., and, Klann E., (2010) mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 33, 67-75.
35. Hoeffer C. A., Tang W., Wong H., et al,. (2008) Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative/repetitive behavior. Neuron 60, 832-845.
36. Hosokawa N., Hara T., Kaizuka T., et al,. (2009) Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol. Biol. Cell 20, 1981-1991.
37. Hsu P. P., Kang S. A., Rameseder J., et al,. (2011) The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317-1322.
38. Hyman S. E., Malenka R. C., and, Nestler E. J., (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 29, 565-598. (Pubitemid 44476856)
39. Jaworski J., and, Sheng M., (2006) The growing role of mTOR in neuronal development and plasticity. Mol. Neurobiol. 34, 205-219.
40. Jernigan C. S., Goswami D. B., Austin M. C., Iyo A. H., Chandran A., Stockmeier C. A., and, Karolewicz B., (2011) The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 1774-1779.
41. Jobim P. F., Pedroso T. R., Christoff R. R., Werenicz A., Maurmann N., Reolon G. K., and, Roesler R., (2012a) Inhibition of mTOR by rapamycin in the amygdala or hippocampus impairs formation and reconsolidation of inhibitory avoidance memory. Neurobiol. Learn. Mem. 97, 105-112.
42. Jobim P. F., Pedroso T. R., Werenicz A., Christoff R. R., Maurmann N., Reolon G. K., Schroder N., and, Roesler R., (2012b) Impairment of object recognition memory by rapamycin inhibition of mTOR in the amygdala or hippocampus around the time of learning or reactivation. Behav. Brain Res. 228, 151-158.
43. Koob G. F., and, Volkow N. D., (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35, 217-238.
44. Koren I., Reem E., and, Kimchi A., (2010) Autophagy gets a brake: DAP1, a novel mTOR substrate, is activated to suppress the autophagic process. Autophagy 6, 1179-1180.
45. Kwiatkowski D. J., and, Manning B. D., (2005) Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum. Mol. Genet. 14 Spec No. 2, R251-R258. (Pubitemid 41631882)
46. Lamming D. W., and, Sabatini D. M., (2013) A central role for mTOR in lipid homeostasis. Cell Metab. 18, 465-469.
47. Lamming D. W., Ye L., Katajisto P., et al,. (2012) Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335, 1638-1643.
48. Laplante M., and, Sabatini D. M., (2012) mTOR signaling in growth control and disease. Cell 149, 274-293.
49. Laplante M., and, Sabatini D. M., (2013) Regulation of mTORC1 and its impact on gene expression at a glance. J. Cell Sci. 126, 1713-1719.
50. Lee C. C., Huang C. C., Wu M. Y., and, Hsu K. S., (2005) Insulin stimulates postsynaptic density-95 protein translation via the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway. J. Biol. Chem. 280, 18543-18550.
51. Li N., Lee B., Liu R. J., Banasr M., Dwyer J. M., Iwata M., Li X. Y., Aghajanian G., and, Duman R. S., (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329, 959-964.
52. Liao L., Pilotte J., Xu T., Wong C. C., Edelman G. M., Vanderklish P., and, Yates J. R., 3rd, (2007) BDNF induces widespread changes in synaptic protein content and up-regulates components of the translation machinery: an analysis using high-throughput proteomics. J. Proteome Res. 6, 1059-1071. (Pubitemid 46480470)
53. Lin J., Liu L., Wen Q., Zheng C., Gao Y., Peng S., Tan Y., and, Li Y., (2014) Rapamycin prevents drug seeking via disrupting reconsolidation of reward memory in rats. Int. J. Neuropsychopharmacol. 17, 127-136.
54. Liu K., Lu Y., Lee J. K., et al,. (2010) PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat. Neurosci. 13, 1075-1081.
55. Liu-Yesucevitz L., Bassell G. J., Gitler A. D., Hart A. C., Klann E., Richter J. D., Warren S. T., and, Wolozin B., (2011) Local RNA translation at the synapse and in disease. J. Neurosci. 31, 16086-16093.
56. Lovinger D. M., White G., and, Weight F. F., (1989) Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243, 1721-1724. (Pubitemid 19106970)
57. Lu L., Koya E., Zhai H., Hope B. T., and, Shaham Y., (2006) Role of ERK in cocaine addiction. Trends Neurosci. 29, 695-703. (Pubitemid 44794537)
58. Lu P., Wang Y., Graham L., et al,. (2012) Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell 150, 1264-1273.
59. Ma X. M., and, Blenis J., (2009) Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10, 307-318.
60. Ma X. M., Yoon S. O., Richardson C. J., Julich K., and, Blenis J., (2008) SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs. Cell 133, 303-313. (Pubitemid 351508301)
61. Mac Callum P. E., Hebert M., Adamec R. E., and, Blundell J., (2013) Systemic inhibition of mTOR kinase via rapamycin disrupts consolidation and reconsolidation of auditory fear memory. Neurobiol. Learn. Mem. S1074-7427(13)00173-1.
62. Maiese K., Chong Z. Z., Shang Y. C., and, Wang S., (2013) mTOR: on target for novel therapeutic strategies in the nervous system. Trends Mol. Med. 19, 51-60.
63. Majumder S., Caccamo A., Medina D. X., Benavides A. D., Javors M. A., Kraig E., Strong R., Richardson A., and, Oddo S., (2012) Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1beta and enhancing NMDA signaling. Aging Cell 11, 326-335.
64. Mameli M., Balland B., Lujan R., and, Luscher C., (2007) Rapid synthesis and synaptic insertion of GluR2 for mGluR-LTD in the ventral tegmental area. Science 317, 530-533. (Pubitemid 47196120)
65. Mazei-Robison M. S., Koo J. W., Friedman A. K., et al,. (2011) Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons. Neuron 72, 977-990.
66. Mendoza M. C., Er E. E., and, Blenis J., (2011) The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem. Sci. 36, 320-328.
67. Miller C. A., and, Marshall J. F., (2005) Molecular substrates for retrieval and reconsolidation of cocaine-associated contextual memory. Neuron 47, 873-884. (Pubitemid 41266953)
68. Myskiw J. C., Rossato J. I., Bevilaqua L. R., Medina J. H., Izquierdo I., and, Cammarota M., (2008) On the participation of mTOR in recognition memory. Neurobiol. Learn. Mem. 89, 338-351. (Pubitemid 351318273)
69. Narita M., Akai H., Kita T., et al,. (2005) Involvement of mitogen-stimulated p70-S6 kinase in the development of sensitization to the methamphetamine-induced rewarding effect in rats. Neuroscience 132, 553-560.
70. Neasta J., Ben Hamida S., Yowell Q., Carnicella S., and, Ron D., (2010) Role for mammalian target of rapamycin complex 1 signaling in neuroadaptations underlying alcohol-related disorders. Proc. Natl Acad. Sci. USA 107, 20093-20098.
71. Neasta J., Ben Hamida S., Yowell Q. V., Carnicella S., and, Ron D., (2011) AKT signaling pathway in the nucleus accumbens mediates excessive alcohol drinking behaviors. Biol. Psychiatry 70, 575-582.
72. Nestler E. J., (2005) Is there a common molecular pathway for addiction? Nat. Neurosci. 8, 1445-1449. (Pubitemid 41573654)
73. Ozaita A., Puighermanal E., and, Maldonado R., (2007) Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain. J. Neurochem. 102, 1105-1114. (Pubitemid 47174245)
74. Park K. K., Liu K., Hu Y., Kanter J. L., and, He Z., (2010) PTEN/mTOR and axon regeneration. Exp. Neurol. 223, 45-50.
75. Polakiewicz R. D., Schieferl S. M., Gingras A. C., Sonenberg N., and, Comb M. J., (1998) mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control. J. Biol. Chem. 273, 23534-23541. (Pubitemid 28417546)
76. Puighermanal E., Marsicano G., Busquets-Garcia A., Lutz B., Maldonado R., and, Ozaita A., (2009) Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat. Neurosci. 12, 1152-1158.
77. Puighermanal E., Busquets-Garcia A., Gomis-Gonzalez M., Marsicano G., Maldonado R., and, Ozaita A., (2013) Dissociation of the pharmacological effects of THC by mTOR blockade. Neuropsychopharmacology 38, 1334-1343.
78. Ron D., and, Messing R. O., (2013) Signaling pathways mediating alcohol effects. Curr. Top. Behav. Neurosci. 13, 87-126.
79. Ron D., and, Wang J., (2009) The NMDA receptor and alcohol, in Biology of the NMDA Receptor (, Van Dongen AM,., ed.), Chapter 4. CRC Press, Boca Raton, FL.
80. Russo S. J., Dietz D. M., Dumitriu D., Morrison J. H., Malenka R. C., and, Nestler E. J., (2010) The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends Neurosci. 33, 267-276.
81. Sanchis-Segura C., and, Spanagel R., (2006) Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict. Biol. 11, 2-38. (Pubitemid 46696746)
82. Santini E., Heiman M., Greengard P., Valjent E., and, Fisone G., (2009) Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia. Sci. Signal. 2, ra36.
83. Sarbassov D. D., Ali S. M., Sengupta S., Sheen J. H., Hsu P. P., Bagley A. F., Markhard A. L., and, Sabatini D. M., (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22, 159-168.
84. Schratt G. M., Nigh E. A., Chen W. G., Hu L., and, Greenberg M. E., (2004) BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development. J. Neurosci. 24, 7366-7377. (Pubitemid 39100705)
85. Shehata M., Matsumura H., Okubo-Suzuki R., Ohkawa N., and, Inokuchi K., (2012) Neuronal stimulation induces autophagy in hippocampal neurons that is involved in AMPA receptor degradation after chemical long-term depression. J. Neurosci. 32, 10413-10422.
86. Slipczuk L., Bekinschtein P., Katche C., Cammarota M., Izquierdo I., and, Medina J. H., (2009) BDNF activates mTOR to regulate GluR1 expression required for memory formation. PLoS ONE 4, e6007.
87. Spanagel R., (2009) Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol. Rev. 89, 649-705.
88. Sparks C. A., and, Guertin D. A., (2010) Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy. Oncogene 29, 3733-3744.
89. Spilman P., Podlutskaya N., Hart M. J., Debnath J., Gorostiza O., Bredesen D., Richardson A., Strong R., and, Galvan V., (2010) Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS ONE 5, e9979.
90. Steketee J. D., and, Kalivas P. W., (2011) Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol. Rev. 63, 348-365.
91. Stoica L., Zhu P. J., Huang W., Zhou H., Kozma S. C., and, Costa-Mattioli M., (2011) Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. Proc. Natl Acad. Sci. USA 108, 3791-3796.
92. Stuber G. D., Hopf F. W., Tye K. M., Chen B. T., and, Bonci A., (2010) Neuroplastic alterations in the limbic system following cocaine or alcohol exposure. Curr. Top. Behav. Neurosci. 3, 3-27.
93. Sui L., Wang J., and, Li B. M., (2008) Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex. Learn. Mem. 15, 762-776.
94. Sutton M. A., and, Schuman E. M., (2006) Dendritic protein synthesis, synaptic plasticity, and memory. Cell 127, 49-58. (Pubitemid 44466643)
95. Swiech L., Perycz M., Malik A., and, Jaworski J., (2008) Role of mTOR in physiology and pathology of the nervous system. Biochim. Biophys. Acta 1784, 116-132.
96. Szumlinski K. K., Kalivas P. W., and, Worley P. F., (2006) Homer proteins: implications for neuropsychiatric disorders. Curr. Opin. Neurobiol. 16, 251-257.
97. Takei N., Inamura N., Kawamura M., Namba H., Hara K., Yonezawa K., and, Nawa H., (2004) Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites. J. Neurosci. 24, 9760-9769. (Pubitemid 39463557)
98. Tang S. J., Reis G., Kang H., Gingras A. C., Sonenberg N., and, Schuman E. M., (2002) A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc. Natl Acad. Sci. USA 99, 467-472. (Pubitemid 34060384)
99. Thoreen C. C., Chantranupong L., Keys H. R., Wang T., Gray N. S., and, Sabatini D. M., (2012) A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485, 109-113.
100. Torres C. A., and, Sulzer D., (2012) Macroautophagy can press a brake on presynaptic neurotransmission. Autophagy 8, 1540-1541.
101. Tzschentke T. M., (2007) Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict. Biol. 12, 227-462. (Pubitemid 47196347)
102. Valjent E., Corvol J. C., Pages C., Besson M. J., Maldonado R., and, Caboche J., (2000) Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci. 20, 8701-8709.
103. Valjent E., Pages C., Rogard M., Besson M. J., Maldonado R., and, Caboche J., (2001) Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission. Eur. J. Neurosci. 14, 342-352. (Pubitemid 32777639)
104. Valjent E., Pages C., Herve D., Girault J. A., and, Caboche J., (2004) Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur. J. Neurosci. 19, 1826-1836. (Pubitemid 38482570)
105. Vanderschuren L. J., and, Pierce R. C., (2010) Sensitization processes in drug addiction. Curr. Top. Behav. Neurosci. 3, 179-195.
106. Vezina C., Kudelski A., and, Sehgal S. N., (1975) Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J. Antibiot. 28, 721-726.
107. Wang J., Carnicella S., Phamluong K., Jeanblanc J., Ronesi J. A., Chaudhri N., Janak P. H., Lovinger D. M., and, Ron D., (2007) Ethanol induces long-term facilitation of NR2B-NMDA receptor activity in the dorsal striatum: implications for alcohol drinking behavior. J. Neurosci. 27, 3593-3602. (Pubitemid 46515141)
108. Wang J., Lanfranco M. F., Gibb S. L., Yowell Q. V., Carnicella S., and, Ron D., (2010a) Long-lasting adaptations of the NR2B-containing NMDA receptors in the dorsomedial striatum play a crucial role in alcohol consumption and relapse. J. Neurosci. 30, 10187-10198.
109. Wang X., Luo Y. X., He Y. Y., Li F. Q., Shi H. S., Xue L. F., Xue Y. X., and, Lu L., (2010b) Nucleus accumbens core mammalian target of rapamycin signaling pathway is critical for cue-induced reinstatement of cocaine seeking in rats. J. Neurosci. 30, 12632-12641.
110. Weston M. C., Chen H., and, Swann J. W., (2012) Multiple roles for mammalian target of rapamycin signaling in both glutamatergic and GABAergic synaptic transmission. J. Neurosci. 32, 11441-11452.
111. Wong E., and, Cuervo A. M., (2010) Integration of clearance mechanisms: the proteasome and autophagy. Cold Spring Harb. Perspect. Biol. 2, a006734.
112. Wu J., McCallum S. E., Glick S. D., and, Huang Y., (2011) Inhibition of the mammalian target of rapamycin pathway by rapamycin blocks cocaine-induced locomotor sensitization. Neuroscience 172, 104-109.
113. Yang H., Rudge D. G., Koos J. D., Vaidialingam B., Yang H. J., and, Pavletich N. P., (2013) mTOR kinase structure, mechanism and regulation. Nature 497, 217-223.
114. Yip C. K., Murata K., Walz T., Sabatini D. M., and, Kang S. A., (2010) Structure of the human mTOR complex I and its implications for rapamycin inhibition. Mol. Cell 38, 768-774.
115. Yu Y. H., Yoon S. O., Poulogiannis G., et al,. (2011) Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332, 1322-1326.
116. Zhu P. J., Huang W., Kalikulov D., et al,. (2011) Suppression of PKR promotes network excitability and enhanced cognition by interferon-gamma- mediated disinhibition. Cell 147, 1384-1396.
117. Zoncu R., Efeyan A., and, Sabatini D. M., (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21-35.